RecallRadar

CPSC recall 23070

Samnyte Tattoo Numbing Creams

On 2022-12-15 the CPSC announced a recall of Samnyte Tattoo Numbing Creams by Sainite Trading Shenzhen, citing the packaging is not child resistant as required by the Poison Prevention Packaging Act. The tattoo numbing cream contains lidocaine, posing a risk of poisoning to young children….

Read the official CPSC notice

AgencyCPSC
Recall number23070
ClassificationNot classified
Statusunknown
Initiated2022-12-15
Published2022-12-15
Last updated2026-09-13 11:58 UTC
CompanySainite Trading Shenzhen
DistributionUS

Product

Samnyte Tattoo Numbing Creams | The recall involves Samnyte Tattoo Numbing Cream sold in 60ml and contains Lidocaine 5% with Vitamin E. The product was sold in a white tube with a flip-top closure. The drug facts label is on the back.

Reason

The packaging is not child resistant as required by the Poison Prevention Packaging Act. The tattoo numbing cream contains lidocaine, posing a risk of poisoning to young children if they ingest it.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: unknown.

Source

Official record: https://www.cpsc.gov/Recalls/2023/Samnyte-Tattoo-Numbing-Creams-Recalled-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Sold-Exclusively-at-Amazon-com-Risk-of-Poisoning-Imported-by-Liu-Xianli

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.